Medulloepithelioma is an uncommon tumour which arises from undifferentiated non-pigmented ciliary epithelium and which usually presents in childhood. Very rarely it may arise in optic nerve or retina. The tumour is pleomorphic and diagnosis is often delayed.
The tumour usually grows slowly and may be locally malignant. Distant metastasis is uncommon and has been described only in cases where orbital spread has occurred. Broughton Pertinent biographical data are presented in Table  1 . There were nine females and seven males. The ages at diagnosis ranged from 6 weeks to 48 years and the follow-up from three months to 25 years.
Results

CLINICAL FEATURES
The presenting symptoms are detailed in Table 2 and the pretreatment signs in Table 3 . The surgical management and histological classification of the surgical specimens are recorded in Table 1 . Twelve cases had primary enucleation and all were alive without clinical tumour recurrence. Three of these had extrascleral extension of the tumour, one of whom received adjuvant radiotherapy. These three patients have been followed for between 5 and 11 years.
Four patients initially had iridocyclectomies, either in order to make the diagnosis or in an attempt to excise the tumour. All four have since required enucleation -two for recurrent intraocular tumour, one for reduced vision and pain, and one for rubeotic glaucoma. One of these patients, with persistent intraocular tumour, had recurrent tumour in the orbit two years after enucleation. This was treated with exenteration and radiotherapy. The patient had no further clinical metastasis after 11 years. The other three all had tumour cells at the site of the previous surgical section when the whole eye was examined, but the patients have remained clinically free of tumour. Two have been followed up for 11 years and one for six months.
HISTOLOGICAL FEATURES
Sixteen cases were reviewed. Occasionally the rosettes have turned 'inside-out', and both of the latter types of rosettes resembled those seen in dysplastic retinas, especially those associated with trisomy 13-15.
It is interesting that heteroplastic cartilage is also associated with this trisomy and with some microphthalmic eyes. This is the most easily recognised heteroplastic or teratoid element. In the present series only two tumours had mature cartilage. Recognition of genuinely teratoid elements can be difficult. In several of our cases areas which appeared to be 'brain' were in fact composed only of glial elements, many showing the well described spongioblastic change, while some appeared gemistocytic. Unequivocal neurone cell bodies were rare but were seen in two cases. We did not regard ganglion cells as being teratoid. Other glial concomitants such as Rosenthal fibres were seen, and one tumour contained frank astrocytomatous areas. Rhabdomyoblasts were seen in one specimen at the Institute of Ophthalmology from a patient on whom biographical data were not available, but not in any of the 16 documented cases reported here.
These tumours present a spectrum of malignancy. While most behave well, without overt aggressive invasion, the AFIP series included four deaths from tumour.
CLINICAL FEATURES
Rubeosis was a clinical or histological feature of 13 of the 16 cases in this study, as compared with only 11 of 56 cases in the AFIP series. It may be a useful confirmatory sign when making the diagnosis. We know of no work on angiogenic factors in these tumours.
The life expectancy of treated patients is very good. In the present series all 15 patients with followup are alive, with no evidence of residual tumour. All affected eyes had been removed, however. In the AFIP series the presence of orbital involvement was a major determinant of survival,' though the present series includes survivors even with extrascleral extension of tumours containing cytological evidence of malignancy.
The best treatment for these patients is uncertain. The tumour is too uncommon for any one centre to have acquired much experience in different therapeutic strategies. Broughton and Zimmerman suggest that local excision be attempted for small, well circumscribed tumours. They base this recommendation on two patients who had had excision iridocyclectomies with no apparent tumour recurrence after a follow-up of between 1 and 22 years. The age of the patients at treatment is not given, nor is their subsequent visual function or the presence of cataract, rubeosis, glaucoma, or squint. Given the usual onset of these tumours in early childhood, one might anticipate that such surgery would result in significant amblyopia. Furthermore, it is not clear whether complete excision of the tumours was achieved: the possibility of corneoscleral extension, which is one of the criteria of malignancy, may have been difficult to exclude.
In the same series, eight eyes which had undergone iridectomy or iridocyclectomy as an initial procedure required later enucleation, making the overall chance of retaining the eye after such surgery 20%. The tumour is typically friable and difficult to manipulate surgically. Although about one-half of the tumours contain melanin pigment microscopically, ' We recommend that enucleation should be the primary treatment for most cases. Where a credible non-neoplastic differential diagnosis exists, incisional biopsy may be considered with a view to subsequent radiotherapy for localised tumours and enucleation for extensive tumours.
